Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04455841
What this trial is testing

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

Who this might be right for
AnemiaPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis
Incyte Corporation 84
Large-scale testing (Phase 3)Not Yet RecruitingNCT07595939
What this trial is testing

Efficacy and Safety of Ruxolitinib Cream in Chinese Children Aged 2-11 Years With Non-segmental Vitiligo

Who this might be right for
Vitiligo
The Children's Hospital of Zhejiang University School of Medicine 20
Testing effectiveness (Phase 2)Looking for participantsNCT06991101
What this trial is testing

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerGlioblastoma Multiforme+4 more
Baptist Health South Florida 190
Testing effectiveness (Phase 2)Ended earlyNCT04908735
What this trial is testing

Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplant (HSCT)Bronchiolitis Obliterans (BO)
Children's Hospital Medical Center, Cincinnati 7
Early research (Phase 1)Looking for participantsNCT03571321
What this trial is testing

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaALL, ChildhoodALL
University of Chicago 15
Large-scale testing (Phase 3)Active Not RecruitingNCT03165734
What this trial is testing

Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Swedish Orphan Biovitrum 407
Testing effectiveness (Phase 2)Looking for participantsNCT06261021
What this trial is testing

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
Innovaderm Research Inc. 20
Testing effectiveness (Phase 2)Looking for participantsNCT05592015
What this trial is testing

Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocyte Leukemia
Jonathan Brammer 30
Testing effectiveness (Phase 2)WithdrawnNCT05909943
What this trial is testing

Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Relapse
Tianjin Medical University General Hospital
Testing effectiveness (Phase 2)Study completedNCT05247489
What this trial is testing

Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo

Who this might be right for
Vitiligo
Incyte Corporation 55
Large-scale testing (Phase 3)Study completedNCT01493414
What this trial is testing

INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.

Who this might be right for
Myelofibrosis
Novartis Pharmaceuticals 2,233
Early research (Phase 1)WithdrawnNCT02528877
What this trial is testing

Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

Who this might be right for
Acute Myeloid Leukemia in RemissionPrimary MyelofibrosisPrimary Myelofibrosis, Prefibrotic Stage+2 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT03701698
What this trial is testing

Ruxolitinib and Steroid As First Line Therapy for Acute GVHD

Who this might be right for
Acute GVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT06388564
What this trial is testing

Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host-disease
Incyte Corporation 130
Testing effectiveness (Phase 2)UnknownNCT05075681
What this trial is testing

Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital 50
Large-scale testing (Phase 3)Study completedNCT05663827
What this trial is testing

Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease

Who this might be right for
Steroid Refractory GVHD
Yi-Lun Wang 6
Testing effectiveness (Phase 2)Looking for participantsNCT06770842
What this trial is testing

Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
The University of Hong Kong 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05998408
What this trial is testing

JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure

Who this might be right for
Severe Aplastic AnemiaSingle Lineage Cytopenias, T-LGLHypoplastic MDS
National Heart, Lung, and Blood Institute (NHLBI) 13
Testing effectiveness (Phase 2)Study completedNCT04896385
What this trial is testing

Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)

Who this might be right for
Vitiligo
Incyte Corporation 60
Early research (Phase 1)Study completedNCT02593760
What this trial is testing

Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)

Who this might be right for
Myelofibrosis
Hoffmann-La Roche 10
Next Page